This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dale, C. J. Articles by Kent, S. J. Search for Related Content PubMed PubMed Citation Articles by Dale, C. J. Articles by Kent, S. J.

Efficacy of DNA and Fowlpox Virus Priming/Boosting Vaccines for Simian/Human Immunodeficiency Virus

C. J. Dale,^1, R. De Rose,^1, I. Stratov,¹ S. Chea,¹ D. C. Montefiori,² S. Thomson,³ I. A. Ramshaw,³ B. E. H. Coupar,⁴ D. B. Boyle,⁴ M. Law,⁵ and S. J. Kent^1*

Department of Microbiology and Immunology, University of Melbourne, Melbourne,¹ CSIRO Livestock Industries, Geelong,⁴ John Curtin School of Medical Research, Australian National University, Canberra,³ National Centre for HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia,⁵ Department of Surgery, Duke University Medical Center, Durham, North Carolina²

Received 31 March 2004/ Accepted 4 August 2004

Further advances are required in understanding protection from AIDS by T-cell immunity. We analyzed a set of multigenic simian/human immunodeficiency virus (SHIV) DNA and fowlpox virus priming and boosting vaccines for immunogenicity and protective efficacy in outbred pigtail macaques. The number of vaccinations required, the effect of DNA vaccination alone, and the effect of cytokine (gamma interferon) coexpression by the fowlpox virus boost was also studied. A coordinated induction of high levels of broadly reactive CD4 and CD8 T-cell immune responses was induced by sequential DNA and fowlpox virus vaccination. The immunogenicity of regimens utilizing fowlpox virus coexpressing gamma interferon, a single DNA priming vaccination, or DNA vaccines alone was inferior. Significant control of a virulent SHIV challenge was observed despite a loss of SHIV-specific proliferating T cells. The outcome of challenge with virulent SHIV_mn229 correlated with vaccine immunogenicity except that DNA vaccination alone primed for protection almost as effectively as the DNA/fowlpox virus regimen despite negligible immunogenicity by standard assays. These studies suggest that priming of immunity with DNA and fowlpox virus vaccines could delay AIDS in humans.

Contributed equally to the work.

This article has been cited by other articles:

• Smith, M. Z., Asher, T. E., Venturi, V., Davenport, M. P., Douek, D. C., Price, D. A., Kent, S. J. (2008). Limited Maintenance of Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8 T-Cell Receptor Clonotypes after Virus Challenge. J. Virol. 82: 7357-7368 [Abstract] [Full Text]  
• Petravic, J., Loh, L., Kent, S. J., Davenport, M. P. (2008). CD4+ Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo. J. Virol. 82: 4091-4101 [Abstract] [Full Text]  
• Koopman, G., Mortier, D., Hofman, S., Mathy, N., Koutsoukos, M., Ertl, P., Overend, P., van Wely, C., Thomsen, L. L., Wahren, B., Voss, G., Heeney, J. L. (2008). Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian human immunodeficiency virus viraemia with protein/DNA combination. J. Gen. Virol. 89: 540-5533 [Abstract] [Full Text]  
• Peut, V., Kent, S. J. (2007). Utility of Human Immunodeficiency Virus Type 1 Envelope as a T-Cell Immunogen. J. Virol. 81: 13125-13134 [Abstract] [Full Text]  
• Chen, L., Ewing, D., Subramanian, H., Block, K., Rayner, J., Alterson, K. D., Sedegah, M., Hayes, C., Porter, K., Raviprakash, K. (2007). A Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus Macaques. J. Virol. 81: 11634-11639 [Abstract] [Full Text]  
• Rollman, E., Smith, M. Z., Brooks, A. G., Purcell, D. F. J., Zuber, B., Ramshaw, I. A., Kent, S. J. (2007). Killing Kinetics of Simian Immunodeficiency Virus-Specific CD8+ T Cells: Implications for HIV Vaccine Strategies. J. Immunol. 179: 4571-4579 [Abstract] [Full Text]  
• Loh, L., Batten, C. J., Petravic, J., Davenport, M. P., Kent, S. J. (2007). In Vivo Fitness Costs of Different Gag CD8 T-Cell Escape Mutant Simian-Human Immunodeficiency Viruses for Macaques. J. Virol. 81: 5418-5422 [Abstract] [Full Text]  
• Fernandez, C. S., Smith, M. Z., Batten, C. J., De Rose, R., Reece, J. C., Rollman, E., Venturi, V., Davenport, M. P., Kent, S. J. (2007). Vaccine-Induced T Cells Control Reversion of AIDS Virus Immune Escape Mutants. J. Virol. 81: 4137-4144 [Abstract] [Full Text]  
• De Rose, R., Batten, C. J., Smith, M. Z., Fernandez, C. S., Peut, V., Thomson, S., Ramshaw, I. A., Coupar, B. E. H., Boyle, D. B., Venturi, V., Davenport, M. P., Kent, S. J. (2007). Comparative Efficacy of Subtype AE Simian-Human Immunodeficiency Virus Priming and Boosting Vaccines in Pigtail Macaques. J. Virol. 81: 292-300 [Abstract] [Full Text]  
• Liang, X., Casimiro, D. R., Schleif, W. A., Wang, F., Davies, M.-E., Zhang, Z.-Q., Fu, T.-M., Finnefrock, A. C., Handt, L., Citron, M. P., Heidecker, G., Tang, A., Chen, M., Wilson, K. A., Gabryelski, L., McElhaugh, M., Carella, A., Moyer, C., Huang, L., Vitelli, S., Patel, D., Lin, J., Emini, E. A., Shiver, J. W. (2005). Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys. J. Virol. 79: 12321-12331 [Abstract] [Full Text]  
• Wu, L., Kong, W.-p., Nabel, G. J. (2005). Enhanced Breadth of CD4 T-Cell Immunity by DNA Prime and Adenovirus Boost Immunization to Human Immunodeficiency Virus Env and Gag Immunogens. J. Virol. 79: 8024-8031 [Abstract] [Full Text]  
• Stratov, I., Dale, C. J., Chea, S., McCluskey, J., Kent, S. J. (2005). Induction of T-Cell Immunity to Antiretroviral Drug-Resistant Human Immunodeficiency Virus Type 1. J. Virol. 79: 7728-7737 [Abstract] [Full Text]  
• Fernandez, C. S., Stratov, I., De Rose, R., Walsh, K., Dale, C. J., Smith, M. Z., Agy, M. B., Hu, S.-l., Krebs, K., Watkins, D. I., O'Connor, D. H., Davenport, M. P., Kent, S. J. (2005). Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost. J. Virol. 79: 5721-5731 [Abstract] [Full Text]  
• Chea, S., Dale, C. J., De Rose, R., Ramshaw, I. A., Kent, S. J. (2005). Enhanced Cellular Immunity in Macaques following a Novel Peptide Immunotherapy. J. Virol. 79: 3748-3757 [Abstract] [Full Text]